Hanrahan, E., Ryan, A., Mann, H., Kennedy, S., Langmuir, P., Natale, R., . . . Heymach, J. (2009). Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non-small cell lung cancer.
Chicago Style (17th ed.) CitationHanrahan, E., A. Ryan, H. Mann, S. Kennedy, P. Langmuir, R. Natale, R. Herbst, B. Johnson, and J. Heymach. Baseline Vascular Endothelial Growth Factor Concentration as a Potential Predictive Marker of Benefit from Vandetanib in Non-small Cell Lung Cancer. 2009.
MLA引文Hanrahan, E., et al. Baseline Vascular Endothelial Growth Factor Concentration as a Potential Predictive Marker of Benefit from Vandetanib in Non-small Cell Lung Cancer. 2009.
警告:這些引文格式不一定是100%准確.